	Can machine learning predict endometrial cancer in patients with postmenopausal uterine bleeding? Prz Menopauzalny Gluska H, Gnaiem N, Katz AA, Miller N, Tzidki A, Baron A, Hants Y, Beiner M, Asali A. PMID: 42460257 [PubMed]
	Cardiovascular toxicity of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in HR+/HER2- breast cancer: a real-world study based on the FAERS database. Front Pharmacol Ma S, Li L, Chen Y, Zhao Y. PMID: 42460021 [PubMed]
	A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support. Front Artif Intell Nannepaga JS, Kandati K, Matam M, Lohitha Nayeneni S, Priya Adem M. PMID: 42459767 [PubMed]
	Exploring the lived experiences of women with breast cancer: a qualitative study across different stages of the disease. Front Public Health Almaqhawi A, Albahrani S, Turkistani JA, Almulhim A. PMID: 42459478 [PubMed - in process]
	Association between frailty and breast cancer incidence and construction of a breast cancer prediction model based on machine learning. Front Public Health Li N, Liu J, You M, Chen Y, Chen M, Huang W, Huang J, Wu F. PMID: 42459460 [PubMed - in process]
	Radiomics analysis of biplanar ultrasound images can discriminate non-mass breast carcinoma from mastitis. Front Oncol Wu Q, Liu G, Xiao M, Xie S, Teng W, Dong Y, Chen X, Liu T, Huang P. PMID: 42459318 [PubMed]
	Ferroptosis in chemotherapy resistance and resensitization in breast cancer: a systematic review of preclinical evidence and translational implications. Front Oncol Shen K, Zhang H, Cai L. PMID: 42459317 [PubMed]
	Survival outcomes of low-dose and high-dose bevacizumab front-line maintenance in advanced high-grade serous ovarian cancer: a propensity score-matched real-world study. Front Oncol Wu T, Shen Y, Wang X, Xi R, Hu L, Lu J, Wang G, Zhang P. PMID: 42459309 [PubMed]
	Evolution and future directions of bispecific antibodies in breast cancer: a global clinical trial landscape analysis. Future Sci OA Zhu X, Luo S, Li Y. PMID: 42459152 [PubMed]
	Boronic Acid-Functionalized MOFs Enable Ultrasensitive Proteomic Profiling of Ultratrace Plasma for Triple-Negative Breast Cancer Diagnosis. Anal Chem Zhang S, Xu Z, Yan H, Shi Y, Ding X, Shen G, Jiang L, Ding X. PMID: 42458930 [PubMed - as supplied by publisher]
	Implementation and initial outcomes of a breast cancer screening program in remote areas: a case study in the western Amazon, Brazil. Rural Remote Health Negreiros AMR, Silva T, Teixeira AV, Fecury I, Mauad EC, Haikel Junior RL, Carvalho AL, de Paula LLRJ. PMID: 42458657 [PubMed - in process]
	Magnetic resonance biomarkers in detection and characterisation of ovarian cancer: is magnetic resonance spectroscopy ready for clinical use? Cancer Imaging Papoutsaki MV, Miquel ME, Martin J, Ordidge K, Sahdev A. PMID: 42458643 [PubMed - as supplied by publisher]
	Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plans. Radiat Oncol Lohm G, Neumann K, Thieß N, Medenwald D, Weinstrauch E. PMID: 42458572 [PubMed - in process]
	The role of ferroptosis in the pathogenesis and treatment of breast cancer. J Transl Med Zhang M, Han Q, Zhao X, Liu W, Lu M, Li X. PMID: 42458449 [PubMed - as supplied by publisher]
	Clinical prognostic value of homologous recombination repair axis markers and PARP1 expression in breast cancer: a systematic review, meta-analysis, and independent cohort validation. BMC Cancer Shen K, Cai L, Wu W. PMID: 42458320 [PubMed - as supplied by publisher]
	Enhanced MobileNet with multi-scale feature fusion for automated breast cancer histopathology classification. Sci Rep Ali ME, Ghalwash AZ, Abdo A. PMID: 42457794 [PubMed - in process]
	Incremental Cancer Detection and False-Positive Burden of Screening Ultrasound After Negative Digital Breast Tomosynthesis: A 10-Year, 100,000-Examination Retrospective Study. Acad Radiol Dodelzon K, Shah S, Intorcia B, Marlow A, Thomas C, Drotman M, Kazam J, Min R, Katzen JT. PMID: 42457499 [PubMed - as supplied by publisher]
	Serum (1)H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer. J Proteome Res Ali A, Tengku Din TADAA, Maulidiani M, Arafat HM, Abdul Rahman WFW, Mazuwin Yahya M, Kadiman S, Ramli RAB, Wan Azman WN. PMID: 42457245 [PubMed - as supplied by publisher]
	Core genes drive treatment resistance in triple-negative breast cancer: characteristics, mechanisms, intervention strategies. Biochem Pharmacol Zhang ZX, Zhao W, Xiao YX, Shen XL, Ming M, Zhou MS, Jia H. PMID: 42456830 [PubMed - as supplied by publisher]
	Ultra-hypofractionated whole breast irradiation in early-stage breast cancer: an Italian multi-centre observational study. Int J Radiat Oncol Biol Phys Palumbo I, Becchetti AG, D'Angelo E, De Santis MC, Fozza A, Lazzari G, Falivene S, Baldissera A, Ingrosso G, De Felice F, Nuzzo M, Anselmo P, Marazzi F, Carnevale MG, Blandino G, Musu AR, Cucciarelli F, Rago L, Andrulli AD, Mascioni F, Ferraioli P, Macchia G, Antonello M, Prisco A, La Rocca E, Alessandro M, Fiorentino A, Fontana A, Barbara R, Bacchiddu S, Bonzano E, Campoccia S, Bini V, Aristei C. PMID: 42456782 [PubMed - as supplied by publisher]

Articles 1 - 20 / 332229

Page 1 of 16612



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy